Cytokinetics, Incorporated (CYTK)

NASDAQ: CYTK · Real-Time Price · USD

62.34

+2.10 (3.49%)

At close: Feb 6, 2026, 4:00 PM EST

61.00

-1.34 (-2.15%)

After-hours: Feb 6, 2026, 7:39 PM EST

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016	Dec '15 Dec 31, 2015	Dec '14 Dec 31, 2014	Dec '13 Dec 31, 2013	Dec '12 Dec 31, 2012
Research and Development Revenue	7.86M	3.47M	4.03M
Research and Development Revenue Growth	126.19%	-13.80%	-38.83%
Milestone Revenue	-	15.00M	3.50M
Milestone Revenue Growth	-	328.57%	250.00%
Revenue (Total)	7.86M	18.47M	7.53M
Revenue (Total) Growth	-57.46%	145.34%	-92.04%

Updated Sep 30, 2025. Data Source: Fiscal.ai.